Diagnostic significance of noncoding RNAs in kawasaki disease: A systematic review and meta-analysis

Xiaoling Zhong; Xufeng Jia; Hui Wang; Guihua Chen; Hongxia Li; Pingping Li; Taoyi Yang; Jiang Xie

doi:10.3389/fped.2022.1071434

Diagnostic significance of noncoding RNAs in kawasaki disease: A systematic review and meta-analysis

Front Pediatr. 2023 Jan 16:10:1071434. doi: 10.3389/fped.2022.1071434. eCollection 2022.

Authors

Xiaoling Zhong¹, Xufeng Jia¹, Hui Wang¹, Guihua Chen¹, Hongxia Li¹, Pingping Li¹, Taoyi Yang¹, Jiang Xie¹

Affiliation

¹ Department of Pediatrics, The Third People's Hospital of Chengdu/The Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.

Abstract

Objective: Kawasaki disease (KD) is a systemic vasculitis disease, and early effective intervention would reduce the occurrence of coronary artery lesions (CALs). Recently, many scholars have been committed to studying the relationship between noncoding RNAs and KD. This systematic review aimed to analyze the diagnostic value of noncoding RNAs(ncRNAs) in distinguishing different KD status.

Methods: We searched for the literature about diagnostic values of ncRNAs in KD in CNKI, VIP, Wanfang, China Biomedical Literature Database as well as PubMed, Web of Science, Embase, and Cochrane Library up to April 15, 2022. All included studies were further analyzed using STATA 12.0, Meta-disc 1.4 and RevMan 5.4 software.

Results: A total of six studies investigating the diagnostic performance of ncRNAs in differentiating KD-CAL (n = 101) from KD-NCAL patients (n = 123) were included in this this meta-analysis. The calculated area under the curve(AUC) was 0.83 (0.80-0.86). Four studies on the diagnostic performance of ncRNAs in differentiating acute KD patients (n = 139) from convalescent KD patients (n = 109) were included. The calculated AUC was 0.87 (0.84-0.90). Four studies focused on the diagnostic performance of ncRNAs combined with other laboratory indexes in KD by assessing 137 KD patients and 152 febrile controls. The calculated AUC was 0.90 (0.87-0.92). Four studies assessed the diagnostic performance of ncRNAs in differentiating intravenous immunoglobulin (IVIG)-resistant KD patients from IVIG-responsive KD patients. The calculated AUC was 0.9135 ± 0.0307. These results indicated that ncRNAs have a good diagnostic efficacy in KD.

Conclusions: This meta-analysis showed that ncRNAs have potential as a biomarker for distinguishing different KD status. However, since limited studies were included in this meta-analysis, larger and well-designed diagnostic studies should be conducted to validate these results.

Systematic review registration: INPLASY.COM, identifier: doi: 10.37766/inplasy2022.10.0035.

Keywords: biomarker; diagnosis; kawasaki disease; meta-analysis; noncoding RNA.

Publication types

Review